Purpose: There is a growing interest in slowing the progression of myopia. This arises from
its increasing prevalence, the sight-threatening consequences of higher levels, and
the growing evidence-based literature supporting a variety of therapies for its control.
Nonetheless, some may say, “Why should we worry about slowing it?” This presentation
quantifies the risk of myopic maculopathy associated with each dioptre of myopia.
To read this article in full you will need to make a payment
Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
© 2019 Published by Elsevier Inc.